CD73 Is a Critical Immune Checkpoint in a Molecular Subtype of Pancreatic Cancer

被引：1
|
作者：
DelGiorno, Kathleen [1 ,2 ,3 ,4 ]
机构：
[1] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Vanderbilt Digest Dis Res Ctr, Nashville, TN 37232 USA
[3] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[4] Vanderbilt Univ, Sch Med, Cell & Dev Biol, 465 21st Ave South, Nashville, TN 37232 USA
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
CELL;
D O I：
10.1158/0008-5472.CAN-23-0268
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：977 / 978
页数：2
相关论文
共 50 条
  • [1] The Ectopyrase CD73 Is a Critical Checkpoint in Thromboinflammation
    Panicker, Sumith R.
    Wang, Jintao
    Becicka, Wyatt
    Wigerblad, Gustaf
    Berreby, Gil
    Garrad, Evan
    Moitra, Jaideep
    Fujii, Takeo
    Agasti, Suchhanda
    Moreno, Eries Jay
    Murray, Elizabeth
    Toney, Bernard
    Osgood, Sharon
    Cowling, Bretagne
    Huffstutler, Rebecca
    Carney, Katherine
    Ferrante, Elisa
    Elmer, Francesca
    Mackman, Nigel
    Brofferio, Alessandra
    Knight, Jason
    Boehm, Manfred
    Tourdot, Benjamin
    Kanthi, Yogendra
    BLOOD, 2024, 144 : 807 - 808
  • [2] CD73: a new immune checkpoint for leukemia treatment
    Gao, Huan
    Zhang, Tingting
    Li, Ke
    Li, Xia
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [3] CD73: an emerging checkpoint for cancer immunotherapy
    Chen, Siqi
    Wainwright, Derek A.
    Wu, Jennifer D.
    Wan, Yong
    Matei, Daniela E.
    Zhang, Yi
    Zhang, Bin
    IMMUNOTHERAPY, 2019, 11 (11) : 983 - 997
  • [4] The impact of CD73 immune checkpoint blockade on procoagulant tissue factor
    Garrad, Evan
    Panicker, Sumith
    Moitra, Jaideep
    Kanthi, Yogen
    VASCULAR MEDICINE, 2023, 28 (05) : 506 - 506
  • [5] The CD73 immune checkpoint promotes tumor cell metabolic fitness
    Allard, David
    Cousineau, Isabelle
    Ma, Eric H.
    Allard, Bertrand
    Bareche, Yacine
    Fleury, Hubert
    Stagg, John
    ELIFE, 2023, 12
  • [6] The distinct role of CD73 in the progression of pancreatic cancer
    Liangjing Zhou
    Shengnan Jia
    Yan Chen
    Weiming Wang
    Zhengrong Wu
    Weihua Yu
    Mingjie Zhang
    Guoping Ding
    Liping Cao
    Journal of Molecular Medicine, 2019, 97 : 803 - 815
  • [7] The distinct role of CD73 in the progression of pancreatic cancer
    Zhou, Liangjing
    Jia, Shengnan
    Chen, Yan
    Wang, Weiming
    Wu, Zhengrong
    Yu, Weihua
    Zhang, Mingjie
    Ding, Guoping
    Cao, Liping
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2019, 97 (06): : 803 - 815
  • [8] CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer
    Chen, Qiangda
    Pu, Ning
    Yin, Hanlin
    Zhang, Jicheng
    Zhao, Guochao
    Lou, Wenhui
    Wu, Wenchuan
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (15) : 8674 - 8686
  • [9] Identification of CD73 and A2AR/CD73 small molecule inhibitors for cancer immunotherapy as single agents or in combination with Immune-checkpoint therapies
    Fons, Pierre
    Bell, Andrew
    Esquerre, Michael
    Versluys, Stephanie
    Bertrand, Florie
    Schreyer, Adrian
    Hopkins-Navratilova, Iva
    Hernani, Leonardo-Silvestre
    Bergeaud, Celia
    Poussereau-Pomie, Celine
    Marchand, Ghislaine
    Robinson, Sean
    Culurgioni, Simone
    Cox, Richard
    Besnard, Jeremy
    Payne, Andrew
    Ray, Peter
    Pelissier, Emilie
    Paillasse, Michael
    Lisztwan, Joanna
    Johnstone, Craig
    Whittaker, Mark
    Hopkins, Andrew
    CANCER RESEARCH, 2019, 79 (13)
  • [10] Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR
    Ploeg, Emily Maria
    Samplonius, Douwe Freerk
    Xiong, Xiao
    Ke, Xiurong
    Hendriks, Mark Alexander Johannes Martinus
    Britsch, Isabel
    van Wijngaarden, Anne Paulien
    Zhang, Hao
    Helfrich, Wijnand
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (09)
12345